Source: Annual Congress 2004 - Pleural and lower respiratory tract infections and bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ilonidis, G. Anogianakis, I. Giavazis, E. Theofilogiannakos, P. Glouftsios, A. Anogeianaki (Thessaloniki, Greece). Diagnostic importance of quantitative evaluation of plasma CRP in COPD. Eur Respir J 2004; 24: Suppl. 48, 3889

Member's Comments

No comment yet.

Related content which might interest you: The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Diagnostic utility of diaphragm ultrasound for discriminating severity in COPD patients Source: International Congress 2019 – Thoracic ultrasound in clinical practice Year: 2019 Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Serum procalcitonin level: clinical significance Source: Eur Respir J 2011; 37: 723 Year: 2011 Association of serum bilirubin and clinical outcomes in COPD Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Association of serum pneumoproteins with clinical course of COPD Source: International Congress 2017 – COPD biomarkers Year: 2017